|
|
Volumn 51, Issue 2, 2009, Pages 162-163
|
|
Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin e
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID;
ALPHA TOCOPHEROL;
BACLOFEN;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CITALOPRAM;
CLONAZEPAM;
CLOZAPINE;
DOPAMINE RECEPTOR;
FREE RADICAL;
NEUROLEPTIC AGENT;
PROPRANOLOL DERIVATIVE;
PSYCHOTROPIC AGENT;
RESERPINE;
TETRABENAZINE;
TRIFLUOPERAZINE;
TRIHEXYPHENIDYL;
VALPROIC ACID;
VIGABATRIN;
ABSENCE OF SIDE EFFECTS;
ADD ON THERAPY;
ADULT;
AGE DETERMINATION;
ANXIETY DISORDER;
BACKACHE;
CASE REPORT;
DEPRESSION;
DIABETES MELLITUS;
DISEASE COURSE;
DISEASE DURATION;
DRUG DOSE INCREASE;
DRUG EXPOSURE;
DRUG MEGADOSE;
DYSPHAGIA;
DYSPNEA;
EVENING DOSAGE;
HUMAN;
INVOLUNTARY MOVEMENT;
LETTER;
MALE;
MOOD DISORDER;
MOUTH;
MOUTH CAVITY;
NECK PAIN;
NEGRO;
ONSET AGE;
PARKINSON DISEASE;
PATHOGENESIS;
PRACTICE GUIDELINE;
PSYCHIATRIST;
RISK FACTOR;
SCHIZOPHRENIA;
SEX DETERMINATION;
SMOKING;
TARDIVE DYSKINESIA;
TONGUE;
TREATMENT OUTCOME;
|
|
EID: 77953424575
PISSN: 00195545
EISSN: 19983794
Source Type: Journal
DOI: 10.4103/0019-5545.49466 Document Type: Letter |
|
Times cited : (8)
|
|
References (8)
|
